![Bryant Lim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bryant Lim
Directeur Financier/CFO chez
PRELUDE THERAPEUTICS INCORPORATED
Fortune : 107 134 $ au 30/09/2026
Profil
Bryant D.
Lim is currently Director at Life Sciences Pennsylvania since 2019.
Mr. Lim is also CFO, Secretary, and Chief Legal Officer at Prelude Therapeutics, Inc. starting in 2024.
Formerly, Mr. Lim was Chief Business Officer, SVP, and General Counsel at Aceragen, Inc. from 2022 to 2023.
Mr. Lim was Secretary, Senior VP, and General Counsel at Idera Pharmaceuticals, Inc. from 2018 to 2022.
Mr. Lim was Chief Compliance Officer and Vice President at Incyte Corp.
from 2014 to 2018.
Mr. Lim worked as Assistant Counsel at Merck & Co., Inc. and as Associate General Counsel at Viropharma, Inc. Education includes undergraduate studies at Rochester Christian University and graduate studies at Villanova University School of Law.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/04/2026 | 27 400 ( 0,04 % ) | 107 134 $ | 30/09/2026 |
Postes actifs de Bryant Lim
| Sociétés | Poste | Début |
|---|---|---|
| PRELUDE THERAPEUTICS INCORPORATED | Directeur Financier/CFO | 08/04/2024 |
Life Sciences Pennsylvania
 Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Provides consulting services to biosciences industry | Directeur/Membre du Conseil | 01/05/2019 |
Anciens postes connus de Bryant Lim
| Sociétés | Poste | Fin |
|---|---|---|
| ACERAGEN, INC. | Conseiller Juridique Général | 17/02/2023 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Conseiller Juridique Général | 01/10/2022 |
| INCYTE CORPORATION | Compliance Officer | 01/09/2018 |
Viropharma, Inc. | Corporate Officer/Principal | - |
| MERCK & CO., INC. | Conseiller Juridique Général | - |
Formation de Bryant Lim
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
58
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Rochester Christian University
 Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Life Sciences Pennsylvania
Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Provides consulting services to biosciences industry | Commercial Services |
Villanova University School of Law
 Villanova University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prelude Therapeutics, Inc.
 Prelude Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines targeting chromatin function to treat cancer and rare diseases | Health Technology |
Viropharma, Inc. | |
Aceragen, Inc.
 Aceragen, Inc. BiotechnologyHealth Technology Discovers, develops, and commercializes therapeutics for oncology and rare diseases | Health Technology |
